Basirat Adeyemi, Pharm D, R Ph
About Basirat Adeyemi, Pharm D, R Ph
Basirat Adeyemi, Pharm D, R Ph, is the Global Medical Affairs, Hematology-Oncology, Asset Lead at Bristol Myers Squibb in the New York City Metropolitan Area. She has extensive experience in regulatory affairs, immuno-oncology, and pharmacy education, having previously worked at Pfizer, Merck, and Rutgers University.
Current Role at Bristol Myers Squibb
Basirat Adeyemi serves as the Global Medical Affairs, Hematology-Oncology, Asset Lead at Bristol Myers Squibb. In this position, she operates within the New York City Metropolitan Area, contributing to the strategic leadership for conditions such as Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Myelofibrosis.
Previous Role at Pfizer
Prior to her current role, Basirat Adeyemi worked at Pfizer as a Global Regulatory Liaison Strategist from 2018 to 2020 in the Greater New York City Area. During this tenure, she built considerable expertise in regulatory affairs.
Postdoctoral Fellowship at Merck
From 2016 to 2018, Basirat Adeyemi was a Postdoctoral Fellow at Merck, focusing on Immuno-Oncology, Vaccines, and Infectious Diseases. This position was based in Rahway, NJ, where she significantly contributed to these critical fields of medical research.
Academic Contributions at Rutgers University
Basirat Adeyemi served as an Adjunct Professor at Rutgers University from 2016 to 2018 in Piscataway, New Jersey. In this role, she shared her knowledge and experience in pharmacy and biomedical sciences with students.
Educational Background
Basirat Adeyemi holds a Doctor of Pharmacy (Pharm.D.) from Touro College of Pharmacy. She also earned a Bachelor of Science in Biology from The George Washington University and pursued Advanced Biomedical Studies at Georgetown University.